Back to Companies who have applied for FDA Drug Approval

FDA Drug Approval Applications Sponsored by MEDIMMUNE ONCOLOGY

Application NumberDrugs/ProductsApplication TypeMost Recent Label Available FlagCurrent Patent FlagAction TypeChemical TypeTher PotentialOrphan Code
020326 New Drug Application Approval New molecular entity (NME) (P*) Priority review drug* (V) Orphan drug

Back to Companies who have applied for FDA Drug Approval